Iron They'll Actually Take1
ACCRUFeR® (ferric maltol) has a unique MALTOL SHIELDTM that protects the iron as it passes through the stomach, resulting in unprecedented GI tolerability and clinically proven efficacy.2,3
See what sets ACCRUFeR apart.
ACCRUFeR® (ferric maltol) is an FDA approved prescription oral iron for the treatment of iron deficiency in adults and children 10 years of age and older.2
Get patients started on ACCRUFeR for as little as $0 with our Patient Savings Program (copay card).*
*Restrictions apply
Free Samples of ACCRUFeR
Your patients deserve a tolerable oral iron treatment. Put ACCRUFeR to the test with free 5-day samples for your patients through MySampleCloset.
Request SamplesReferences:
1. Schmidt C, Ahmad T, Tulassay Z, et al. Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a phase 3 study. Aliment Pharmacol Ther. 2016;44(3):259-270. doi:10.1111/apt.13665
2. ACCRUFeR® full prescribing information. Shield Therapeutics, 2025.
3. Stallmach A, Büning C. Ferric maltol (ST10): a novel oral iron supplement for the treatment of iron deficiency anemia in inflammatory bowel disease. Expert Opin Pharmacother. 2015;16(18):2859-2867. doi:10.1517/14656566.2015.1096929
4. European Medicines Agency. Accessed March 17, 2021. https://www.ema.europa.eu/en/documents/variation-report/feraccru-h-c-2733-ii-0010-epar-assessment-report-variation_en.pdf.
5. Gasche C, Ahmad T, Zsolt T, et al. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program. Inflamm Bowel Dis. 2015;21:579-588.
6. Pergola PE, Kopyt NP. Oral ferric maltol for the treatment of iron-deficiency anemia in patients with CKD: a randomized trial and open-label extension. Am J Kidney Dis. 2021;78(6):846-
856.e1. doi:10.1053/j.ajkd.2021.03.020
7. Data on file. Shield Therapeutics Inc. 2019.